- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: recombinant fowlpox GM-CSF vaccine adjuvant
Total 348 results
-
Bionor Immuno ASCompleted
-
MAXVAX Biotechnology Limited Liability CompanyHenan Center for Disease Control and PreventionActive, not recruiting
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
Central Adelaide Local Health Network IncorporatedNational Health and Medical Research Council, Australia; University of Adelaide and other collaboratorsNot yet recruitingImmunosuppression | Vaccine Response Impaired
-
University of Wisconsin, MadisonGlaxoSmithKlineNot yet recruitingInflammatory Bowel Diseases | IBDUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingBreast Ductal Carcinoma In SituUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Completed
-
University Hospital, GhentCompleted
-
University Hospital TuebingenUnknownRenal Cell Cancer | Advanced Renal Cell Cancer
-
Peking University Cancer Hospital & InstituteRecruiting
-
Marshfield Clinic Research FoundationCenters for Disease Control and PreventionCompleted
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)CompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Peking University Cancer Hospital & InstituteActive, not recruiting
-
Ultimovacs ASAActive, not recruitingProstate CancerNorway
-
Ahmad TarhiniNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Malignant Conjunctival Neoplasm | Melanoma (Skin)United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Chronic Myeloid Leukemia (CML)United States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); The Skip Viragh FoundationCompleted
-
Ultimovacs ASAOslo University HospitalActive, not recruitingA Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer. (UV1-hTERT2012L)Non-small Cell Lung CancerNorway
-
Sinocelltech Ltd.RecruitingHPV Infection Vaccine Safety SCT1000China
-
COL George Peoples, MD, FACSM.D. Anderson Cancer CenterCompletedBreast Cancer | Ovarian CancerUnited States
-
National Cancer Institute (NCI)Completed
-
Duke UniversityJohns Hopkins University; Centers for Disease Control and PreventionCompletedQuality of Life | Pain | Adverse Drug Event | Injection Site ReactionUnited States
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
St George's, University of LondonEuropean UnionCompleted
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Hormone-Resistant Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Completed
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Stage III Ovarian Epithelial Cancer | Stage III Ovarian Germ Cell TumorUnited States
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownPulmonary Alveolar ProteinosisChina
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Safety and Tolerability | Compare SHINGRIX Vaccine Response RatesUnited States
-
National Cancer Institute (NCI)CompletedMultiple Myeloma | Graft vs Host DiseaseUnited States
-
H. Kim LyerlyNational Cancer Institute (NCI)CompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Tehran University of Medical SciencesCompleted
-
Serum Institute of India Pvt. Ltd.Active, not recruitingPrevention of TB RecurrenceBangladesh, India
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic TherapeuticsRecruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Adenocarcinoma | Advanced Adenocarcinoma | Recurrent AdenocarcinomaUnited States
-
Beth Israel Deaconess Medical CenterNational Cancer Institute (NCI); Dana-Farber Cancer InstituteCompletedRenal CancerUnited States
-
Quaid-e-Azam UniversityHealth Services Academy, Islamabad, Pakistan; Medical Research Council, PakistanCompleted
-
Cancer Insight, LLCGenentech, Inc.; Sellas Life Sciences GroupCompleted
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Neoantigen Therapeutics Co., Ltd.RecruitingNeoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical ResectionResectable Esophageal CancerChina
-
National Cancer Institute (NCI)CompletedAdult Acute Myeloid Leukemia in Remission | Accelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Previously Treated Myelodysplastic Syndromes | Relapsing Chronic Myelogenous Leukemia | Refractory Anemia With Excess Blasts | Refractory Anemia With Excess...United States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNo Evidence of Disease | Healthy Stem Cell DonorUnited States
-
Zhejiang Provincial People's HospitalHangzhou Neoantigen Therapeutics Co., Ltd.RecruitingResectable Pancreatic CancerChina
-
CanSino Biologics Inc.Jiangsu Province Centers for Disease Control and Prevention; Beijing Institute...Completed
-
The University of Hong KongCenters for Disease Control and PreventionActive, not recruiting
-
OrienGene Biotechnology Ltd.Unknown
-
D'Or Institute for Research and EducationBill and Melinda Gates Foundation; Instituto Fernandes FigueiraNot yet recruiting
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
University of Maryland, BaltimoreWithdrawn
-
M.D. Anderson Cancer CenterThe Vaccine CompanyTerminated